/
Electromedical & electrotherapeutic apparatus company · L3 · FY ends Dec · Revenue $370M · 23.05% margin · $84M FCF
23.05% operating margin is above average. ROIC at 9.82%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 6.2% YoY. Margins deteriorated 5.5pp alongside, both lines moving the wrong way.
Free cash flow declined 36% versus the prior year, cash generation momentum has weakened. Operating margin contracted 5.5pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$370M
▼ -6.2% YoY
Net Income (TTM)
$94M
▼ -48.2% YoY
Op. Margin
23.05%
▼ -5.5pp YoY
ROIC
9.82%
▼ -2.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$84M
▼ -36.1% YoY
Op. Cash Flow (TTM)
$85M
▼ -35.7% YoY
Net Debt
-$378M
Net Cash Position
Cash & Equiv.
$386M
5Y CAGR: +12.4%
5Y CAGR: +1.4%
Continue Research